MedReleaf leads again with a new first for the Canadian medical cannabis industry

Cannabis Oil Capsules approved for sale by Health Canada

MARKHAM, ON, Nov. 8, 2016 /CNW/ - MedReleaf, Canada's leading medical cannabis licensed producer, today announced it has become the first licensed producer (LP) to bring cannabis capsules to market. This news follows on recent Health Canada approval for MedReleaf to begin selling both cannabis oils and capsules.

Capsules provide access to cannabis for an under-served patient community who are more comfortable taking their medication in traditional capsule form rather than by oil or through vapourizers. For patients and physicians alike, capsules also provide increased confidence and comfort in regard to precise dosing.

Securing approval on easy-to-use capsules provides further evidence of MedReleaf's position as the leader in the field of medical grade cannabis and its commitment to scientific advancement in the industry. 

"MedReleaf is committed to being a leader in cannabis research and development as well as in best understanding patient needs," noted Neil Closner, MedReleaf's CEO.  "Our initial and ongoing commitment to R&D built our reputation as the producer of the highest quality, most consistent cannabis and now it is delivering an industry first that will better serve our patients with improved convenience, ease of use and peace of mind."

"Capsules are a significant step forward for both new and existing patients who prefer a traditional capsule for their medicine," noted Dr. Marissa Slaven, Assistant Professor at McMaster University's Juravinski Cancer Centre. "Capsules also provide a mechanism for more accurate dosing of cannabis which should be very well received by physicians."

Concurrent with approval of its capsules, MedReleaf received approval to begin to sell its unique premium cannabis oils as well and sales of both product lines began Monday November 7^th.

MedReleaf capsule and oil products available for sale now include:

Cannabis Capsules

Product	THC per Capsule	CBD per Capsule	Size
Avidekel Capsules	<2 mg	20 mg	10 per container
Sativa Capsules	5 mg	0 mg	50 per container

Cannabis Oils

Product	Size	THC Content	CBD Content	Total THC	Total CBD
Avidekel Oil	50 ml	1.5 mg / ml	25 mg / ml	70 mg	1250 mg
Sativa Oil	50 ml	25 mg/ml	0 mg / ml	1250 mg	0 mg

Additional capsule and oil products will be released in the coming weeks.

MedReleaf patients and health care professionals are encouraged to go to www.MedReleaf.com to find out more and order product.

About MedReleaf

MedReleaf is the leading, research-and-development driven, medical cannabis producer in Canada and the only ISO 9001 certified cannabis producer in North America. They offer the finest range of premium cannabis products sourced from around the globe and cultivated in their Ontario facility under the strictest guidelines and care. MedReleaf focuses on quality, safety, uniformity, and reliability, and they do it all to improve the quality of life for their patients. MedReleaf is setting The Medical Grade Standard^™, because quality assurance is at the core of every product they produce. Through tireless clinical research in concert with the Canadian medical community, MedReleaf is consistently striving to unlock the immense potential of medical cannabis, and is dedicated to leading the way in the discovery of its medical and therapeutic benefits.

For more information on MedReleaf, its products and processes, please visit MedReleaf.com

SOURCE MedReleaf Corp.

Media Contact: Darren Karasiuk, MedReleaf, 416.580. 8768